Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.
2.

Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates.

Schneerson R, Robbins JB, Chu C, Sutton A, Vann W, Vickers JC, London WT, Curfman B, Hardegree MC, Shiloach J, et al.

Infect Immun. 1984 Sep;45(3):582-91.

3.

Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates.

Schneerson R, Robbins JB, Parke JC Jr, Bell C, Schlesselman JJ, Sutton A, Wang Z, Schiffman G, Karpas A, Shiloach J.

Infect Immun. 1986 May;52(2):519-28.

4.

Studies on Pneumococcus vaccine alone or mixed with DTP and on Pneumococcus type 6B and Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugates in two- to five-year-old children with sickle cell anemia.

Sarnaik S, Kaplan J, Schiffman G, Bryla D, Robbins JB, Schneerson R.

Pediatr Infect Dis J. 1990 Mar;9(3):181-6. Erratum in: Pediatr Infect Dis J 1990 May;9(5):308.

PMID:
2336298
5.

Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines.

Granoff DM, Rathore MH, Holmes SJ, Granoff PD, Lucas AH.

Vaccine. 1993;11 Suppl 1:S46-51. Review.

PMID:
8447176
6.

Effect of transplacentally acquired tetanus antibodies on the antibody responses to Haemophilus influenzae type b-tetanus toxoid conjugate and tetanus toxoid vaccines in Filipino infants.

Nohynek H, Gustafsson L, Capeding MR, Käyhty H, Olander RM, Pascualk L, Ruutu P.

Pediatr Infect Dis J. 1999 Jan;18(1):25-30.

PMID:
9951976
8.

Clinical and immunologic responses to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants injected at 3, 5, 7, and 18 months of age.

Parke JC Jr, Schneerson R, Reimer C, Black C, Welfare S, Bryla D, Levi L, Pavliakova D, Cramton T, Schulz D, et al.

J Pediatr. 1991 Feb;118(2):184-90.

PMID:
1993943
9.
10.
11.
13.

Persistence of serum antibodies elicited by Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants vaccinated at 3, 5 and 12 months of age.

Claesson BA, Schneerson R, Lagergård T, Trollfors B, Taranger J, Johansson J, Bryla D, Robbins JB.

Pediatr Infect Dis J. 1991 Aug;10(8):560-4.

PMID:
1891286
15.
16.

Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children.

Claesson BA, Trollfors B, Lagergard T, Taranger J, Bryla D, Otterman G, Cramton T, Yang Y, Reimer CB, Robbins JB, et al.

J Pediatr. 1988 May;112(5):695-702.

PMID:
3361379
17.

Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants.

Granoff DM, Holmes SJ, Belshe RB, Osterholm MT, McHugh JE, Anderson EL.

JAMA. 1994 Oct 12;272(14):1116-21.

PMID:
7933324
20.

Supplemental Content

Support Center